Psoriasis outcome measures: A report from the GRAPPA 2012 annual meeting

Alice B. Gottlieb, April W. Armstrong

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Psoriasis is a multisystem disease. The cutaneous and musculoskeletal manifestations (psoriatic arthritis) are well recognized. However, the other manifestations of psoriatic disease including metabolic syndrome, atherosclerotic cardiovascular disease, depression, poor self-esteem, and self-destructive habits including obesity, smoking and excess alcohol consumption are underappreciated. At the 2012 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), members addressed the need to develop uniform, validated, standardized outcome measures for psoriatic disease, measures that are useful to all stakeholders including patients, physicians, regulators, and payers.

Original languageEnglish (US)
Pages (from-to)1428-1433
Number of pages6
JournalJournal of Rheumatology
Volume40
Issue number8
DOIs
StatePublished - Aug 2013

Fingerprint

Psoriatic Arthritis
Psoriasis
Outcome Assessment (Health Care)
Skin Manifestations
Group Processes
Metabolic Diseases
Research
Self Concept
Alcohol Drinking
Habits
Cardiovascular Diseases
Obesity
Smoking
Depression
Physicians

Keywords

  • Comorbidities
  • National psoriasis foundation
  • OMERACT
  • Psoriasis
  • Psoriatic disease

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy

Cite this

Psoriasis outcome measures : A report from the GRAPPA 2012 annual meeting. / Gottlieb, Alice B.; Armstrong, April W.

In: Journal of Rheumatology, Vol. 40, No. 8, 08.2013, p. 1428-1433.

Research output: Contribution to journalArticle

Gottlieb, Alice B. ; Armstrong, April W. / Psoriasis outcome measures : A report from the GRAPPA 2012 annual meeting. In: Journal of Rheumatology. 2013 ; Vol. 40, No. 8. pp. 1428-1433.
@article{5d5bb33b69f142beb8732934447c332f,
title = "Psoriasis outcome measures: A report from the GRAPPA 2012 annual meeting",
abstract = "Psoriasis is a multisystem disease. The cutaneous and musculoskeletal manifestations (psoriatic arthritis) are well recognized. However, the other manifestations of psoriatic disease including metabolic syndrome, atherosclerotic cardiovascular disease, depression, poor self-esteem, and self-destructive habits including obesity, smoking and excess alcohol consumption are underappreciated. At the 2012 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), members addressed the need to develop uniform, validated, standardized outcome measures for psoriatic disease, measures that are useful to all stakeholders including patients, physicians, regulators, and payers.",
keywords = "Comorbidities, National psoriasis foundation, OMERACT, Psoriasis, Psoriatic disease",
author = "Gottlieb, {Alice B.} and Armstrong, {April W.}",
year = "2013",
month = "8",
doi = "10.3899/jrheum.130456",
language = "English (US)",
volume = "40",
pages = "1428--1433",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "8",

}

TY - JOUR

T1 - Psoriasis outcome measures

T2 - A report from the GRAPPA 2012 annual meeting

AU - Gottlieb, Alice B.

AU - Armstrong, April W.

PY - 2013/8

Y1 - 2013/8

N2 - Psoriasis is a multisystem disease. The cutaneous and musculoskeletal manifestations (psoriatic arthritis) are well recognized. However, the other manifestations of psoriatic disease including metabolic syndrome, atherosclerotic cardiovascular disease, depression, poor self-esteem, and self-destructive habits including obesity, smoking and excess alcohol consumption are underappreciated. At the 2012 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), members addressed the need to develop uniform, validated, standardized outcome measures for psoriatic disease, measures that are useful to all stakeholders including patients, physicians, regulators, and payers.

AB - Psoriasis is a multisystem disease. The cutaneous and musculoskeletal manifestations (psoriatic arthritis) are well recognized. However, the other manifestations of psoriatic disease including metabolic syndrome, atherosclerotic cardiovascular disease, depression, poor self-esteem, and self-destructive habits including obesity, smoking and excess alcohol consumption are underappreciated. At the 2012 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), members addressed the need to develop uniform, validated, standardized outcome measures for psoriatic disease, measures that are useful to all stakeholders including patients, physicians, regulators, and payers.

KW - Comorbidities

KW - National psoriasis foundation

KW - OMERACT

KW - Psoriasis

KW - Psoriatic disease

UR - http://www.scopus.com/inward/record.url?scp=84881458668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881458668&partnerID=8YFLogxK

U2 - 10.3899/jrheum.130456

DO - 10.3899/jrheum.130456

M3 - Article

C2 - 23908539

AN - SCOPUS:84881458668

VL - 40

SP - 1428

EP - 1433

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 8

ER -